EOLS

Evolus, Inc.

Latest Form 4:Sale$65KbyMOATAZEDI DAVID (See Remarks) · filed Mar 20, 2026

Evolus, Inc. (EOLS) has 15 SEC Form 4 filings (17 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Mar 20, 2026.

The most active filer is See Remarks MOATAZEDI DAVID with 3 filings. Insiders have net sold $888K over the trailing 6 months.

  • Industry:Drug Manufacturers - Specialty & Generic
  • CEO:David Moatazedi
  • Employees:350
  • HQ:Newport Beach, CA, US
  • IPO:2018-02-08

Insider Buying

$0

reported purchases (SEC code P)

Insider Selling

$888K

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Source
Sale$65KMar 20SEC ↗
Sale$15KMar 20SEC ↗
Sale$147KMar 18SEC ↗
Sale$571KMar 18SEC ↗
Avelar RuiFirst filing
Sale$16KDec 29SEC ↗
MOATAZEDI DAVIDFirst filing
Sale$75KDec 29SEC ↗

Related companies

Evolus, Inc. is in the Healthcare sector.